Navigation Links
Faithful mothers have healthier babies
Date:11/12/2009

Faculty of 1000 reviewers examine a study from New Zealand on whether prolonged exposure to the father's semen protects new mothers against pre-eclampsia and having an undersized baby

In this study by Kho and colleagues at the University of Auckland, published in the Journal of Reproductive Immunology, 2507 first-time pregnant women were interviewed about the length of their relationship with the baby's biological father.

When the pregnancies came to term, pre-eclampsia (pregnancy-induced hypertension) was found to be less common in women who had long-term sexual relations exclusively with the biological father, than in those who had been with their partner only for a short time (i.e. less than six months).

The study also revealed that women who had undersized babies (SGA, or 'small for gestational age') were also more likely to have been in shorter relationships, but only when 20 week ultrasounds demonstrated reduced blood flow to the fetus.

F1000 reviewer Dr Larry Chamley explains that "in normal pregnancies prolonged exposure of the female immune system to paternal antigens following intercourse (without barrier contraception) [could induce] tolerance of the maternal immune system to the paternal antigens.

But the exaggerated maternal inflammatory response in pre-eclampsia is due to a failure of the maternal immune system to down-regulate or tolerate its response to paternal antigens."

"Although the issue of whether prolonged semen exposure does protect against developing pre-eclampsia is not yet resolved," continued Dr Chamley, "this paper seems to tip the weight of evidence back in favour of suggesting that prolonged semen exposure is protective."


'/>"/>

Contact: Steve Pogonowski
press@f1000.com
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. Safer, more accurate radiation therapy for expecting mothers
2. Hungry mothers risk addiction in their adult children
3. Negligent, attentive mouse mothers show biological differences
4. Too much or too little weight gain poses risks to pregnant mothers, babies
5. Mice mothers devote energies to offspring when life is threatened
6. Vitamin D deficiency in infants and nursing mothers carries long-term disease risks
7. Mothers pass on disease clues to offspring
8. Facebook flack regarding breastfeeding mothers
9. Older killer whales make the best mothers
10. Mothers of multiple births at increased odds of postpartum depression
11. Mothers give interlopers offspring a head start in life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... December 05, 2016 , ... The Real Dirt ... premier cannabis technology and application experts, Chip Baker. Chip Baker formerly co-founded Royal ... the past 30 years, Chip Baker other industry veterans have made the evolution ...
(Date:12/5/2016)... CHICAGO , December 5, 2016 ... report, "Cell Expansion Market, by Products (Consumable, Instruments, ... Applications (Regenerative Medicine and Stem Cell Research, Cancer, ... Research Institutes, Cell Banks) - Global Revenue, Trends, ... by Scalar Market Research, the global cell expansion ...
(Date:12/5/2016)... - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ... Monitoring Board (DSMB) for the Company,s Phase 3 ... has completed a second planned safety review and ... without any modifications. The DSMB reviewed available study ... concerns were identified. The DSMB will conduct additional ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
Breaking Biology Technology: